Concepedia

Publication | Open Access

Phase I dose‐escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors

13

Citations

23

References

2019

Year

Abstract

The pediatric MTD/dose for further development was identified. There were no unexpected safety or PK findings; limited antitumor/antileukemic activity was demonstrated.

References

YearCitations

Page 1